CannaMed Pharmaceuticals plans to start “quick grow” construction
An empty wearhouse near Hebron may not look like much now, but some big changes will be happening soon.
Despite some pushback from the community, CannaMed Pharmaceuticals is forging ahead with new construction set for next month.
Angeline Nanni, the CEO CannaMed Pharmaceuticals says, “If you can imagine just rows of tables where you have seedlings. That’s what this is going to look like.”
The room Nanni and her business partner Jeff Siskind talked with 47 ABC in on Thursday may look like an empty warehouse space. But, it’ll soon be a “quick start” grow room for their company’s medical marijuana.
Nanni goes on, “We’ll have our water. All of our standard operating procedures will be written. We hope to get that completed within the next month.”
CannaMed’s grower from Colorado will be coming to set it up. It’s exactly what it sounds like, a room to “quickly start” growing medicinal cannabis.
The company has already submitted its growing license application. The state of Maryland will award them in two phases. To get past the first step, potential businesses have to fulfill a lot of requirements like correct zoning and financing. Nanni has no doubt CannaMed Pharmaceuticals will pass.
She goes on, “We want to make sure when the approvals come through we hit the ground running.”
However, this operation isn’t cheap. Jeff Siskind, chairman of CannaMed Pharmaceuticals says, “Our expenditure will be about $80,000 in equipment.”
About $30,000 in soft costs will be spent on top of that for things like electricity and labor. However for Siskind, a price can’t put on the opportunities that could come out of this venture. He’s not thinking just in terms of business, but medicine and research.
The state approves marijuana as medicine to treat a number of afflictions including chronic pain, multiple sclerosis, wasting syndrome, cancer, seizure and glaucoma.
To pass the second phase of approval, CannaMed Pharmaceuticals must essentially stay true to their phase one proposal. If and when that happens, the quick grow room and everything on its six-thousand square foot floor will be dedicated to research.
Siskind goes, “To develop aspects of medicinal use for the plant, no one is really doing it right now.”